Fast and cost-effective protocol to produce Paracoccidioides spp. antigens
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
INST NACIONAL SALUD - Colombia
Autores
Citação
BIOMEDICA, v.43, suppl.1, p.170-180, 2023
Resumo
Introduction. The existing methods for Paracoccidioides spp. antigen production are problematic in terms of standardization, specificity, stability, repeatability, and reproducibility.Objective. To optimize the methodology for Paracoccidioides spp. antigen production and evaluate its applicability in paracoccidioidomycosis immunodiagnosis.Materials and methods. The antigens were obtained from Paracoccidioides lutzii isolates (01, 66, and 8334), Paracoccidioides brasiliensis sensu stricto (113), and Paracoccidioides restripiensis (B-339). These fungi were grown at 36 degrees C +/- 1 degrees C, on modified Fava-Netto agar, according to Freitas et al. (2018). Paracoccidioides lutzii antigens were obtained after 5, 10, and 20 days of culture, whereas P. brasiliensis and P. restripiensis antigens were obtained after 10 days. Antigens were evaluated in natura, 10 and 20 times concentrated. Antigenic capacity was evaluated using a double immunodiffusion assay against serum samples from patients with paracoccidioidomycosis, histoplasmosis, and aspergillosis, and random blood donors.Results. Cross-reactivity between Paracoccidioides spp. antigens was observed when P. brasiliensis, P. restrepiensis antigens, and P. lutzii antigens were evaluated with the polyclonal antibodies against P. lutzii and P. brasiliensis, respectively. No cross-reactivity was obtained for polyclonal antibodies against Histoplasma capsulatum, Aspergillus fumigatus, and random blood donors. The proposed protocol allowed stable, repeatable, and reproducible genus-specific antigen production at a low cost and in a short cultivation time.Conclusion. The proposed protocol allowed us to obtain genus-specific antigens that can be developed and reproduced in all laboratories in Brazil and South America, where paracoccidioidomycosis is a neglected disease, contributing to an early diagnosis, especially in endemic regions, regardless of the species.
Palavras-chave
Paracoccidioides, paracoccidioidomycosis, antigens, immunologic tests
Referências
- Almeida-Paes R, 2022, J FUNGI, V8, DOI 10.3390/jof8100993
- ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5
- Arantes TD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004606
- BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
- Buccheri R, 2018, AM J TROP MED HYG, V98, P1082, DOI 10.4269/ajtmh.17-0812
- Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358
- da Silva JD, 2016, DIAGN MICR INFEC DIS, V84, P87, DOI 10.1016/j.diagmicrobio.2015.06.004
- de Camargo Z P, 2000, Rev Iberoam Micol, V17, P41
- de Camargo ZP, 2008, MYCOPATHOLOGIA, V165, P289, DOI 10.1007/s11046-007-9060-5
- de Freitas RS, 2018, REV IBEROAM MICOL, V35, P27, DOI 10.1016/j.riam.2017.04.004
- Do Valle ACF, 2001, MED MYCOL, V39, P373, DOI 10.1080/714031038
- dos Santos PO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003516
- Esteche VT, 2012, J BRAS PNEUMOL, V38, P264, DOI 10.1590/S1806-37132012000200017
- Fernandes VC, 2011, J IMMUNOL METHODS, V367, P78, DOI 10.1016/j.jim.2011.02.006
- Ferreira CS, 2016, FUTURE MICROBIOL, V11, P973, DOI 10.2217/fmb-2016-0062
- Gegembauer G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002986
- Gonzalez A, 2016, YEAST, V33, P113, DOI 10.1002/yea.3147
- Kamikawa CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0101-3
- Kamikawa CM, 2022, Rev Inst Adolfo Lutz, V81, P1, DOI [10.53393/rial.2022.v.81.37165, DOI 10.53393/RIAL.2022.V.81.37165]
- LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
- Leitao NP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003111
- Lenhard-Vidal A, 2018, MYCOSES, V61, P826, DOI 10.1111/myc.12819
- Vidal MSM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003174
- Martinez R, 2017, J FUNGI, V3, DOI 10.3390/jof3010001
- Mendes JF, 2017, MYCOSES, V60, P402, DOI 10.1111/myc.12608
- Mendes Rinaldo Poncio, 2017, Open Microbiol J, V11, P224, DOI 10.2174/1874285801711010224
- Ortiz BL, 1998, CLIN DIAGN LAB IMMUN, V5, P826, DOI 10.1128/CDLI.5.6.826-830.1998
- OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507
- Peçanha PM, 2022, J FUNGI, V8, DOI 10.3390/jof8101098
- Queiroz LD, 2014, MYCOSES, V57, P466, DOI 10.1111/myc.12183
- Queiroz-Telles F, 2017, LANCET INFECT DIS, V17, pE367, DOI 10.1016/S1473-3099(17)30306-7
- Shikanai-Yasuda MA, 2017, REV SOC BRAS MED TRO, V50, P715, DOI 10.1590/0037-8682-0230-2017
- Vicentini-Moreira AP, 2008, Bol Epidemiol Paul, V5, P11